The future of Health Technology Assessment in Europe
Health Technology Assessment (HTA) is a rapidly evolving process that informs decisions about the benefits, risks, and costs of mainly new technologies, interventions and practices. Over the past 20 years, many European countries have started to use it, though usually to serve fairly narrow objectives. But HTA is developing rapidly, and considerable experience on good and less good practice is now available.
Panos Kanavos, Ulf Persson and Michael Drummond. London School of Economics
Presented at ‘Securing Europe’s Healthcare Future’ conference Prague, February 18th, 2009
Report
19/02/2009
This report discusses these experiences and considers the future of HTA in Europe. It also looks at ways of improving international collaboration. The emphasis is on those HTA activities related to decisions on allocating resources, and on the relationship between the HTA and subsequent decision-making. The report considers four broad themes:
• The structure of HTA activities;
• Methods of HTA;
• Processes for the conduct of HTA; and
• Use of HTA in decision-making.
The growing use of HTA provides a greater opportunity to compare and contrast the various approaches and define best practice. Agreement on best practice is important because HTA is increasingly a fundamental part of the way organisations decide on which health technologies they will reimburse. The report proposes 15 principles and identifies seven important issues for the future. It also considers the key challenges to standardizing HTA in Europe.
The Initiative for Sustainable Healthcare Financing in Europe
Resto de la Unión Europea
- eHealth 2009
- eHealth for Individuals, Society and Economy (February 18-20, 2009)
- Securing Europe´s Healthcare Future:Chronic Disease Management and Health Technology Assessment: Second Report
- Chronic disease is the leading cause of mortality and illness in Europe today, a cause that on current projections is ...
- Managing Chronic Disease in Europe
- Chronic conditions and diseases are the leading cause of mortality and morbidity in Europe, and research suggests that complex conditions ...
